U.S. Healthcare Potentially Undervalued Companies

Xvivo Perfusion

Market Cap: US$9.8b

A medical technology company, develops and markets machines and perfusion solutions for assessing usable organs and maintains in optimal condition pending transplantation in Sweden.

BML

Market Cap: US$111.5b

Provides laboratory testing and related services in Japan.

Galenica

Market Cap: US$3.7b

Operates as a healthcare service provider in Switzerland and internationally.

Bumrungrad Hospital

Market Cap: US$139.5b

Owns and operates healthcare-related entities in Thailand and internationally.

Medley

Market Cap: US$120.2b

Operates platforms for recruitment and medical businesses in Japan and the United States.

Suzuken

Market Cap: US$389.1b

Primarily engages in the distribution of pharmaceuticals in Japan and internationally.

Peijia Medical

Market Cap: US$3.6b

Engages in the research and development of transcatheter valve therapeutic and neuro interventional procedural medical devices.

Teleflex

Market Cap: US$5.6b

Designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide.

FONAR

Market Cap: US$79.5m

Engages in the designing, manufacturing, and selling magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases, abnormalities, other medical conditions, and injuries in the United States.

Vitalhub

Market Cap: US$624.1m

Engages in the provision of technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally.

QHSLab

Market Cap: US$1.9m

A medical device technology and software-as-a-service SaaS company, focuses on value-based healthcare, informatics, and algorithmic personalized medicine including digital therapeutics.

GoodRx Holdings

Market Cap: US$1.6b

Offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States.

Electromed

Market Cap: US$190.2m

Develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally.

Venus Concept

Market Cap: US$2.5m

A medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally.

HealthEquity

Market Cap: US$7.9b

Provides technology-enabled services platforms to consumers and employers in the United States.

WELL Health Technologies

Market Cap: US$983.8m

Operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally.

Amedisys

Market Cap: US$3.1b

Provides healthcare services in the United States.

ResMed

Market Cap: US$35.9b

Develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets.

InVitro International

Market Cap: US$1.5m

Develops test kits for non-animal testing applications in the United States and internationally.

MedPeerInc

Market Cap: US$10.4b

Offers services for doctors and pharmacists in Japan.

COLTENE Holding

Market Cap: US$304.8m

Develops, manufactures, and sells disposables, tools, and equipment for dentists and dental laboratories in Europe, the Middle East, Africa, North America, Latin America, and Asia/Oceania.

Escalon Medical

Market Cap: US$1.4m

Engages in the development, manufacturing, marketing, and distribution of medical devices and pharmaceuticals for ophthalmic applications in the United States and internationally.

Lifeward

Market Cap: US$14.6m

A medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally.

Cytosorbents

Market Cap: US$54.4m

Engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology in the United States, Germany, and internationally.

Pennant Group

Market Cap: US$971.0m

Provides healthcare services in the United States.

Nuwellis

Market Cap: US$4.2m

A medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy.

PAVmed

Market Cap: US$21.0m

Engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States.

Sonova Holding

Market Cap: US$15.6b

Manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific.

Cerus

Market Cap: US$260.0m

Operates as a biomedical products company.

Haemonetics

Market Cap: US$3.4b

A healthcare company, provides suite of medical products and solutions in the United States and internationally.

STRATA Skin Sciences

Market Cap: US$10.4m

A medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America.

Phreesia

Market Cap: US$1.5b

Provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada.

P3 Health Partners

Market Cap: US$61.4m

A patient-centered and physician-led population health management company, provides superior care services in the United States.

23andMe Holding

Market Cap: US$24.1m

Operates as a consumer genetics testing company in the United States, the United Kingdom, Canada, and internationally.

Andlauer Healthcare Group

Market Cap: US$2.1b

A supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States.

Jinxin Fertility Group

Market Cap: US$9.1b

An investment holding company, provides assisted reproductive services (ARS) in China and the United States.